Shareholder Votes

Kayne DL 2021, Inc. shareholders approved To elect the following individuals as director for a term of three years (until the 2029 Annual Meeting of Stockholders) and until successors are duly elected and qualified. at the 2026-06-11 meeting.

“Proposal 1. To elect the following individuals as director for a term of three years (until the 2029 Annual Meeting of Stockholders) and until successors are duly elected and qualified. The following votes were taken in connection with this proposal: Director Nominee For Against Abstain Broker Non-Votes Albert (Al) Rabil III 67,180 – – – Susan C. Schnabel 67,180 – – –”

COLUMBIA SPORTSWEAR CO shareholders rejected Proxy Access shareholder proposal.

“5. Proxy Access . The shareholder proposal regarding proxy access was rejected with the following votes: For Against Abstentions Broker Non-Votes 13,880,262 34,042,003 42,251 1,648,084”

COLUMBIA SPORTSWEAR CO shareholders approved Approval of Columbia Sportswear Company Amended and Restated 2020 Stock Incentive Plan.

“4. Approval of 2020 Stock Incentive Plan . The proposal to approve the Columbia Sportswear Company Amended and Restated 2020 Stock Incentive Plan passed with the following votes: For Against Abstentions Broker Non-Votes 41,006,074 6,931,794 26,648 1,648,084”

COLUMBIA SPORTSWEAR CO shareholders approved Approval of Executive Compensation.

“3. Approval of Executive Compensation . The proposal to approve, by non-binding vote, executive compensation passed with the following votes: For Against Abstentions Broker Non-Votes 47,847,695 98,053 18,768 1,648,084”

COLUMBIA SPORTSWEAR CO shareholders approved Ratification of Deloitte & Touche LLP.

“2. Ratification of Deloitte & Touche LLP . The proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2026 was approved as follows: For Against Abstentions 49,393,337 205,267 13,996”

COLUMBIA SPORTSWEAR CO shareholders approved Election of Directors.

“1. Election of Directors . The following persons were elected as directors of the Company by the votes cast as follows: Votes For Votes Against or Withheld Broker Non-Votes Timothy P. Boyle 47,824,163 140,353 1,648,084 Stephen E. Babson 47,364,749 599,767 1,648,084 Andy D. Bryant 46,397,053 1,567,463 1,648,084 John W. Culver 47,857,934 106,582 1,648,084 Charles D. Denson 47,929,494 35,022 1,648,084 Kevin Mansell 47,067,087 897,429 1,648,084 Ronald E. Nelson 47,796,858 167,658 1,648,084 Christiana Smith Shi 47,889,964 74,552 1,648,084 Sabrina L. Simmons 47,885,378 79,138 1,648,084 Malia H. Wasson 47,426,852 537,664 1,648,084”

Kayne Anderson BDC, Inc. shareholders approved To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-11 meeting.

“Proposal 2. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The following votes were taken in connection with this proposal: For Against Abstain Broker Non-Votes 42,074,039 264,230 17,910 –”

Kayne Anderson BDC, Inc. shareholders approved To elect the following individuals as director for a term of three years (until the 2029 Annual Meeting of Stockholders) and until successors are duly elected and qualified. at the 2026-06-11 meeting.

“Proposal 1. To elect the following individuals as director for a term of three years (until the 2029 Annual Meeting of Stockholders) and until successors are duly elected and qualified. The following votes were taken in connection with this proposal: Director Nominee For Against Abstain Broker Non-Votes Albert (Al) Rabil III 41,616,226 259,190 48,325 432,438 Susan C. Schnabel 40,815,781 1,060,128 47,832 432,438”

Global Self Storage, Inc. shareholders approved Non-Binding Advisory Vote on Executive Compensation.

“Proposal 4: Non-Binding Advisory Vote on Executive Compensation Approval on an advisory basis, the Company's executive compensation. For Against Abstain Broker Non-Vote 3,710,166 1,303,882 70,923 2,985,927”

Global Self Storage, Inc. shareholders approved Ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-12-31 meeting.

“Proposal 3: Ratification of Accounting Firm Ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Vote 7,636,317 338,816 95,765 N/A”

Global Self Storage, Inc. shareholders approved Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan..

“Proposal 2: Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan. Approval of the amendment and restatement of the Company's 2017 Equity Incentive Plan. For Against Abstain Broker Non-Vote 3,717,027 1,298,704 69,240 2,985,927”

Global Self Storage, Inc. shareholders approved Election of directors to serve until the 2027 Annual Stockholder Meeting.

“Proposal 1: Election of Directors Election of Mark C. Winmill as a director to serve until the 2027 Annual Stockholder Meeting and until his successor is duly elected and qualifies. For Withheld Broker Non-Vote 4,072,265 1,012,706 2,985,927 Election of Russell E. Burke III as a director to serve until the 2027 Annual Stockholder Meeting and until his successor is duly elected and qualifies. For Withheld Broker Non-Vote 3,876,399 1,208,572 2,985,927 Election of William C. Zachary as a director to serve until the 2027 Annual Stockholder Meeting and until his successor is duly elected and qualifies. For Withheld Broker Non-Vote 3,881,675 1,203,296 2,985,927 Election of George B. Langa as a director to serve until the 2027 Annual Stockholder Meeting and until his successor is duly elected and qualifies. For Withheld Broker Non-Vote 3,393,054 1,691,917 2,985,927 Election of Sally C. Carroll, Esq. as a director to serve until the 2027 Annual Stockholder Meeting and until her successor is dul”

Norwegian Cruise Line Holdings Ltd. shareholders approved Approval of amendment to the 2013 Plan to increase share reserve at the 2026-06-11 meeting.

“4. Approval of Amendment to 2013 Plan For Against Abstain Broker Non-Votes 262,009,659 9,510,085 660,274 91,672,477”

Norwegian Cruise Line Holdings Ltd. shareholders approved Advisory vote on frequency of future Say-on-Pay votes at the 2026-06-11 meeting.

“3. Advisory Vote on the Frequency of Future Say-on-Pay Votes 1 Year 2 Years 3 Years Abstain 265,317,260 498,761 5,418,226 945,771”

Norwegian Cruise Line Holdings Ltd. shareholders approved Advisory vote on executive compensation (Say-on-Pay) at the 2026-06-11 meeting.

“2. Advisory Vote on Executive Compensation For Against Abstain Broker Non-Votes 233,387,448 38,145,401 647,169 91,672,477”

Norwegian Cruise Line Holdings Ltd. shareholders approved Election of three Class I directors at the 2026-06-11 meeting.

“1. Election of Directors Nominee For Against Abstain Broker Non-Votes Zillah Ellen Byng-Thorne 247,005,384 24,111,797 1,062,837 91,672,477 Alex Cruz 267,945,117 3,693,105 541,796 91,672,477 Linda P. Jojo 258,428,913 12,948,760 802,345 91,672,477”

INTENSITY THERAPEUTICS, INC. shareholders approved Approval of any postponement or adjournment of 2026 annual meeting, if necessary at the 2026-06-16 meeting.

“For Against Abstain 939,304 126,814 13,376”

INTENSITY THERAPEUTICS, INC. shareholders approved Approval of amendment to 2024 Employee Stock Purchase Plan to increase shares available by 25,000 at the 2026-06-16 meeting.

“For Against Abstain Broker Non-Votes 407,404 25,350 3,324 643,416”

INTENSITY THERAPEUTICS, INC. shareholders approved Approval of amendment to 2021 Stock Incentive Plan to increase shares available by 150,000 at the 2026-06-16 meeting.

“For Against Abstain Broker Non-Votes 363,563 69,252 3,263 643,416”

INTENSITY THERAPEUTICS, INC. shareholders approved Ratification of selection of EisnerAmper LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-16 meeting.

“For Against Abstain 1,024,971 4,852 49,671”

INTENSITY THERAPEUTICS, INC. shareholders approved Election of two Class III directors to hold office until the 2029 annual meeting at the 2026-06-16 meeting.

“Nominee For Withheld Broker Non-Votes Dr. Emer Leahy 416,613 19,465 643,416 Lewis H. Bender 422,149 13,929 643,416”

MIMEDX GROUP, INC. shareholders approved Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“Proposal 3: Ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes Total Shares Voted 123,687,080 1,640,474 33,411 N/A”

MIMEDX GROUP, INC. shareholders approved Advisory approval of executive compensation at the 2026-06-10 meeting.

“Proposal 2: Advisory approval of executive compensation. For Against Abstain Broker Non-Votes Total Shares Voted 95,158,451 4,369,645 2,223,856 23,609,013”

MIMEDX GROUP, INC. shareholders approved Election of Nine Directors at the 2026-06-10 meeting.

“Proposal 1: Election of Nine Directors. For Against Abstain Broker Non-Votes Joseph H. Capper 99,286,347 2,395,447 70,158 23,609,013 James L. Bierman 96,181,316 5,500,069 70,567 23,609,013 William A. Hawkins, III 98,237,248 3,417,906 96,798 23,609,013 K. Todd Newton 96,493,668 5,219,808 38,476 23,609,013 Tiffany Olson 98,657,185 2,984,080 110,687 23,609,013 Dorothy Puhy 98,645,942 2,993,132 112,878 23,609,013 Martin P. Sutter 97,032,156 4,617,992 101,804 23,609,013”

Vaxcyte, Inc. shareholders approved Approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers at the 2026-06-15 meeting.

“3. The approval, on a non-binding, advisory basis of the compensation of the Company's named executive officers. The approval of the non-binding resolution on named executive officer compensation was approved by the votes indicated: For Against Abstain Broker Non-Votes 130,011,017 2,755,868 247,195 4,354,403”

Vaxcyte, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-15 meeting.

“2. The ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. The appointment was ratified by the votes indicated: For Against Abstain 137,230,032 137,589 862”

Vaxcyte, Inc. shareholders approved Election of three Class III directors to serve until the Company's 2029 Annual Meeting of Stockholders at the 2026-06-15 meeting.

“1. The election of three nominees to serve as Class III directors until the Company’s 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director’s death, resignation or removal. The following three Class III directors were re-elected by the votes indicated: For Withheld Broker Non-Votes Olivier Brandicourt, M.D. 116,370,183 16,643,897 4,354,403 Halley Gilbert, J.D. 114,704,274 18,309,806 4,354,403 Grant Pickering, M.B.A. 132,112,840 901,240 4,354,403”

John Marshall Bancorp, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.

“The shareholders voted to ratify the appointment of Yount, Hyde & Barbour, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

John Marshall Bancorp, Inc. shareholders approved Election of Directors at the 2026-06-16 meeting.

“The shareholders elected the eight nominees named in the Company’s proxy statement for the Annual Meeting, to serve until the 2027 Annual Meeting of Shareholders and until their successors are elected and qualified.”

SkinHealth Systems Inc. shareholders approved Advisory vote on the compensation of the named executive officers at the 2026-06-10 meeting.

“The Company’s stockholders approved, on an advisory, non-binding basis, the compensation paid by the Company to its named executive officers as disclosed in the Proxy Statement, as follows: Votes For Votes Against Abstentions Broker Non-Votes 58,604,735 12,346,541 1,021,201 21,434,437”

SkinHealth Systems Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-10 meeting.

“The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent, registered public accounting firm for the fiscal year ending December 31, 2026, as follows: Votes For Votes Against Abstentions Broker Non-Votes 93,125,701 235,673 45,540 0”

SkinHealth Systems Inc. shareholders approved Election of nine directors to serve for a one-year term expiring at the 2027 annual meeting at the 2026-06-10 meeting.

“The Company’s stockholders elected the nine directors listed below, each to serve for a term of one year, expiring at the Company's 2027 annual meeting of stockholders or until his or her successor is duly appointed or elected and qualified or until his or her earlier death, resignation, or removal from office, as follows: Nominees Votes For Votes Withheld Broker Non-Votes Brenton L. Saunders 64,713,062 7,259,415 21,434,437 Pedro Malha 70,933,549 1,038,928 21,434,437 E. Scott Beattie 61,017,737 10,954,740 21,434,437 Stephen J. Fanning 68,732,826 3,239,651 21,434,437 Michelle Kerrick 70,684,772 1,287,705 21,434,437 Brian Miller 56,555,107 15,417,370 21,434,437 Doug Schillinger 61,107,166 10,865,311 21,434,437 Sachin Shridharani, M.D. 71,317,162 655,315 21,434,437 Kenneth Tripp 71,078,056 894,421 21,434,437”

Omada Health, Inc. shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-16 meeting.

“Proposal Two – Ratification of the Appointment of Independent Registered Public Accounting Firm FOR AGAINST ABSTAIN 41,550,689 16,905 27,282”

Omada Health, Inc. shareholders approved Election of Class I Directors: Sean Duffy and Trevor Fetter at the 2026-06-16 meeting.

“The final voting results for each of these proposals are as follows: Proposal One - Election of Class I Directors NOMINEE FOR WITHHELD BROKER NON-VOTERS Sean Duffy 18,540,089 9,134,162 13,920,625 Trevor Fetter 18,538,042 9,136,209 13,920,625”

Natera, Inc. shareholders approved Approval of an amendment to the Amended and Restated 2015 Equity Incentive Plan at the 2026-06-11 meeting.

“Proposal 5 : The approval of an amendment to the Amended and Restated 2015 Equity Incentive Plan: For Against Abstentions Broker Non-Votes 95,735,506 26,861,815 123,232 7,970,544”

Natera, Inc. shareholders approved Advisory vote on the frequency of the advisory vote on the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal 4 : The advisory vote on the frequency of the advisory vote on the compensation of the Company’s named executive officers: One Year Two Years Three Years Abstain 121,647,012 36,823 972,982 63,736”

Natera, Inc. shareholders approved Advisory vote on the compensation of the Company’s named executive officers at the 2026-06-11 meeting.

“Proposal 3 : The advisory vote on the compensation of the Company’s named executive officers: For Against Abstentions Broker Non-Votes 119,883,700 2,492,978 343,875 7,970,544”

Natera, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-11 meeting.

“Proposal 2 : The ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: For Against Abstentions Broker Non-Votes 129,786,351 848,088 56,658 0”

Natera, Inc. shareholders approved Election of three Class II directors to serve until the 2029 annual meeting and one Class I director to serve until the 2028 annual meeting at the 2026-06-11 meeting.

“Proposal 1 : The election of three directors to serve as Class II directors until the 2029 annual meeting of stockholders, and the election of one director to serve as a Class I director until the 2028 annual meeting of stockholders, or until his or her successor is duly elected and qualified: Name of Class II Nominee For Withheld Broker Non-Votes Rowan Chapman 106,832,026 15,888,527 7,970,544 Herm Rosenman 103,920,050 18,800,503 7,970,544 Jonathan Sheena 106,940,124 15,780,429 7,970,544 Name of Class I Nominee For Withheld Broker Non-Votes Eric H. Rubin 120,601,658 2,118,895 7,970,544”

Cytek Biosciences, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm at the 2026-06-10 meeting.

“3. Ratification of the Selection of Independent Registered Public Accounting Firm. The selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 110,533,253 479,883 148,354 —”

Cytek Biosciences, Inc. shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.

“2. Executive Compensation. On a non-binding, advisory basis, the compensation paid to the Company’s named executive officers for the year ended December 31, 2025 was approved based on the following results of voting: Votes For Votes Against Abstentions Broker Non-Votes 84,794,380 677,861 21,212 25,668,037”

Cytek Biosciences, Inc. shareholders approved Election of Class II Directors at the 2026-06-10 meeting.

“1. Election of Class II Directors. Each of the following nominees was elected to serve as a Class II director, to hold office until the Company’s 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified or until his or her earlier death, resignation or removal, based on the following results of voting: Nominee Votes For Votes Withheld Broker Non-Votes Vera Imper, Ph.D. 64,769,976 20,723,477 25,668,037 Glenn P. Muir 79,599,103 5,894,350 25,668,037 Ming Yan, Ph.D. 76,741,063 8,752,390 25,668,037”

PUMA BIOTECHNOLOGY, INC. shareholders rejected Amendment to warrant terms to extend expiration at the 2026-06-11 meeting.

“Proposal 4: The Company’s stockholders did not approve an amendment to the terms of the warrant, issued to Alan H. Auerbach, President and Chief Executive Officer of the Company on October 4, 2011, as amended on June 15, 2021, to purchase 2,116,250 shares of the Company’s common stock at $16.00 per share (the “Auerbach Warrant”), to extend the term of the Auerbach Warrant from October 4, 2026 until October 4, 2028. For Against Abstain Broker Non-Votes 18,234,150 19,596,238 85,914 0”

PUMA BIOTECHNOLOGY, INC. shareholders approved Advisory vote on executive compensation at the 2026-06-11 meeting.

“Proposal 3: The Company’s stockholders voted to approve, on an advisory basis, the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 29,326,673 7,878,580 711,049 0”

PUMA BIOTECHNOLOGY, INC. shareholders approved Ratification of KPMG LLP as independent auditor at the 2026-06-11 meeting.

“Proposal 2: The Company’s stockholders ratified the selection of KPMG LLP as the Company’s independent registered accounting firm for the fiscal year ending December 31, 2026. For Against Abstain Broker Non-Votes 42,612,940 1,328,476 39,599 0”

PUMA BIOTECHNOLOGY, INC. shareholders approved Election of eight directors at the 2026-06-11 meeting.

“Proposal 1: The Company’s stockholders elected the eight nominated directors identified below, each to serve and to hold office for a one-year term until the close of the Company’s next annual meeting of stockholders in 2027 and until their successors have been duly elected and qualified or until their earlier resignation or removal. Nominee For Withheld Broker Non-Votes Alan H. Auerbach 37,130,678 785,624 6,064,713 Alessandra Cesano 37,472,173 444,129 6,064,713 Allison Dorval 37,447,432 468,870 6,064,713 Michael P. Miller 37,220,974 695,328 6,064,713 Jay M. Moyes 36,586,798 1,329,504 6,064,713 Adrian M. Senderowicz 37,217,253 699,049 6,064,713 Brian Stuglik 37,372,588 543,714 6,064,713 Troy E. Wilson 32,546,955 5,369,347 6,064,713”

Everforth Inc shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“Proposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm The appointment of Deloitte & Touche LLP to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the Company’s stockholders as follows: For Against Abstain Broker Non-Votes 37,892,330 1,076,312 22,314 —”

Everforth Inc shareholders approved Advisory vote to approve executive compensation for the year ended December 31, 2025 at the 2025-12-31 meeting.

“Proposal 2. Advisory Vote on Executive Compensation The non-binding advisory vote to approve the Company’s executive compensation for the year ended December 31, 2025 was approved as follows: For Against Abstain Broker Non-Votes 35,327,570 798,621 23,070 2,841,695”

Everforth Inc shareholders approved Election of three directors: Mark A. Frantz, Carol J. Lindstrom, and Arshad Matin.

“Proposal 1. Election of Directors The first proposal was the election of three members of the Board of Directors (the “Board”) to serve as directors until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified. Mark A. Frantz, Carol J. Lindstrom and Arshad Matin were elected receiving votes as follows: Nominee For Against Abstain Broker Non-Votes Mark A. Frantz 35,357,706 772,906 18,649 2,841,695 Carol J. Lindstrom 35,595,635 535,121 18,505 2,841,695 Arshad Matin 35,144,146 986,982 18,133 2,841,695”

SHOPIFY INC. shareholders rejected Shareholder proposal regarding an artificial intelligence policy at the 2026-06-16 meeting.

“A shareholder proposal regarding an artificial intelligence policy was not approved.”